KEY PRODUCTS
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
01 1Noramco
01 1TAPENTADOL HYDROCHLORIDE (R331333) DRUG SUBSTANCE
01 1U.S.A
01 1Active
01 1Complete
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Complete
Rev. Date : 2020-08-05
Pay. Date : 2020-07-30
DMF Number : 21084
Submission : 2008-01-23
Status : Active
Type : II
20
Noramco Llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
One of their notable products is TAPENTADOL HYDROCHLORIDE (R331333) DRUG SUBSTANCE, with a corresponding US DMF Number 21084.
Remarkably, this DMF maintains an Active status since its submission on January 23, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 05, 2020, and payment made on July 30, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
